The ATP-sensitive potassium (K ATP ) channels which extensively distribute in diverse tissues (e.g. vascular smooth muscle, cardiac cells, and pancreas) are well-established for characteristics like vasodilatation, myocardial protection against ischemia, and insulin secretion. The aim of this review is to get insight into the novel roles of K ATP channels in Parkinson's disease (PD), with consideration of the specificities K ATP channels in the central nervous system (CNS), such as the control of neuronal excitability, action potential, mitochondrial function and neurotransmitter release.
Introduction
Parkinson's disease (PD) is a most common movement disorder caused by loss of dopaminergic neurons in the substantia nigra pars compacta. For rare forms of familial PD, relevant differences in gene expression have recently been identified (e.g. -synuclein, parkin, UCHL-1, PINK1 and LRRK2), while any of them can not explain the degeneration especially in the sporadic cases. Many hypotheses for the pathogenesis of sporadic PD have been proposed, including oxidative stress, mitochondrial dysfunction, inflammatory process and apoptosis of dopamine neurons and other related cells in substantia nigra. Nevertheless, the precise etiopathogenesis is not understood. Attempts to avoid side effects of the conventional therapy should aim to identify new targets for potential pharmacological intervention. The ATP-sensitive potassium (K ATP ) channels presenting in the control of neuronal excitability, action potential, mitochondrial dysfunction of oxidative stress and neurotransmitter release in the central nervous system (CNS) have been compellingly recognized [1] . Due to their diversity and distinct localizations, the K ATP channels are the interesting candidates for new therapeutic strategies. This review aims to get insight into the novel and crucial roles of K ATP channels in the pathogenesis of PD.
Structure and function of K ATP channels
The existence of K ATP channels was initially discovered in cardiac myocytes by Noma in 1983 [2] and subsequently identified expressed in pancreatic cells by Ashcroft in 1990 [3] . Then it is proved that K ATP channels present characteristics in different tissues, such as vasodilatation in vascular smooth muscle, myocardial protection against ischemia in cardiac cells, and insulin secretion in pancreas [4] . The basic structure of functional K ATP channels is formed by the heteromeric aggregation of four subunit proteins: each subunit consists of a short amino acid sequence, which forms a "loop" into the membrane, and is flanked by two transmembrane domains. The unit may be supplemented by four additional membrane spanning domains, or two units may be combined to a single protein, thus forming three structural classes of potassium channels [4] (Fig. 1a) . As octameric proteins, K ATP channels are heteromultimers of two types of subunits: inward rectifiers, KIR6.x, members of the Kir6 inwardly rectifying potassium channel family and sulfonylurea receptors, SURs, members of the ATP-binding cassette (ABC) transporter superfamily [4] (Fig. 1b, 1c) . Commonly, four pore-forming Kir6 subunits are joined together with four regulatory SUR subunits. However, sometimes the molecular makeup of neuronal K ATP channels also appears to be not homogeneous. Non-proportion of the Kir6.x subunit expression to SUR subunits expression may result in the functional and pharmacological diversity, which will influence the function of neurons, glia, or neuronal networks [5, 7, 8] . At present, two members of the Kir6 family have been cloned, Kir6.1 and Kir6.2; two SUR isoforms have been identified, SUR1 and SUR2 (SUR2A and SUR2B being the most important). With a combined approach of electrophysiological patch-clamp and single-cell mRNA expression profiling techniques, different combinations of co-expressed K ATP channel subunits have been identified. The mRNA encoding K ATP channels comprising Kir6.2 and SUR1 are abundantly expressed in the nigral dopaminergic neurons with properties similar to those described in pancreatic cells. Kir6.2 and SUR2A pairs assemble the K ATP channels of cardiac and skeletal muscle, and SUR2B in combination with Kir6.1 subunits generate K ATP channels in smooth muscle. K ATP channel subunits are also widely expressed throughout different brain regions, e.g. in hippocampal pyramidal neurons, locus coerulus and dorsal vagal neurons, striatal interneurons, hypothalamic neurons, and GABAergic and nigral dopaminergic neurons, and there is also evidence for functional presynaptic K ATP channels [6] [7] [8] .
Roles of K ATP channels in PD
Potassium channels are important components of the signal transduction in the nervous system, which are involved in a wide variety of functions such as setting and stabilizing the resting potential of most cell types or regulating the depolarization time course in pacemaker cells. Other parameters, such as action potential duration, firing frequencies, and interspike intervals are also determined by the activity of K ATP channels. 3.1 K ATP channels' responsiveness to ATP/ADP and electrical activity in PD K ATP channels are metabolic sensors [4] .
that couple cellular energy metabolism to membrane potential by regulating potassium flux. ] i ) [9] [10] [11] . By this mechanism, K ATP channel activity exerts a powerful control of cellular excitability. Besides, neuronal K ATP channels are involved in central glucose sensing, neuroendocrining, glucose homeostasis controlling, electrical activity adapting and neuronal ATP consumption. Oweing to the physiological significance in the cell membrane active potential and threshold potential, K ATP channels are important components of the signal transduction of the nervous system and virtually all other cells of the mammalian body [12] . Under the physiological conditions, dopaminergic neurons in the midbrain demonstrate spontaneous action potential firing and, at least in brain slices in vitro, most K ATP channels are closed. In the context of metabolic dysfunction in PD, K ATP channels are of special interest for their open probability directly according to the metabolic state of a cell. In mouse PD model induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), rapid ATP loss even ATP depletion which has been observed for mitochondrial dysfunction, may contribute to further metabolic disorders and induce the unusual activated open of K ATP channels [11, 13] .The activation of K ATP might play a neuroprotective role by minimizing metabolic demand in cells, reducing action potential firing rate, and leading to a hyperpolarization of the dopaminergic neurons to loss their normal pacemaker activity. The inactivation of dopaminergic neurons via the potassium conductance could be an appropriate response to reduced energy demand. Additionally, K ATP channel-mediated membrane hyperpolarization will reduce neurotransmitter release, which is helpful for counteracting calcium overload and excitotoxicity. Furthermore, the efflux of K ATP , which is the mechanism of recovering (repolarization), maintaining (clamping) and enhancing (hyperpolarization) the resting potential of the cell, represents a potential safeguard against the deleterious process in PD. The outcome of these effects is a reduction in membrane and cell excitability, which results in a greater cellular resistance to activation by excitatory stimuli. As for the increase of oxygen free radicals, augment of lipoperoxides (LPO) level, and overload of [Ca 2+ ] i , N-methyl-D-aspartate (NMDA) receptor-mediated excitatory toxicity eventually lead to neuronal degeneration [6] .Several studies have suggested that cell energy deficiency results in fluctuations in [ATP] i . Regulating K ATP channels through either large changes in the concentration of ATP or through compartmentalization models proposes significant local changes in [ATP] i [9] [10] [11] [12] . 3.2 K ATP channels are associated with mitochondrial dysfunction in PD Morphological, biochemical, molecular genetic, and cell/animal model studies have suggested that the functions and properties of mitochondria have been identified as a crucial trigger factor in neurodegenerative process of PD [13] . In PD, the dysfunction of the mitochondrial electron transport chain leads to the increase of reactive oxygen species or metabolic stress and renders subsets of selectively vulnerable neurons intrinsically susceptible to cellular degeneration and oxidative stress [12] [13] [14] . Mitochondrial K ATP (Mito-K ATP ) channels play the roles in controlling the mitochondrial volume, regulating the translation of metabolic status of cells, and responsing open/ close channels to injury for neurodegeneration. It is hypothesized that preconditioning of K ATP channels may render neuronal tissues resistant to neurodegenerative process [15] . To test this hypothesis , Tai and Truong et al. found that, at the cellular level, activation of K ATP channels in PC12 cells confered protection against mitochondrial complex-I inhibition-induced cell death by rotenone which had been proven to be the pathogenesis of PD [16] . The results suggest that transient activation of K ATP channels can precondition PC12 cells against the neurotoxic effect of a mitochondrial complex I inhibitor. Diazoxide, a mitochondrial K ATP channel selective opener, preconditioned in a dosedependently way to increase PC12 cell viability, while the protective effect of this preconditioning is attenuated by 5-hydroxydecanoic acid (5-HD), a selective mitochondrial K ATP channel antagonist. In contrast, P-1075, a selective plasma membrane K ATP channel opener, did not show the protective effect. Although plasma K ATP channels are not detected on PC12 cell membrane and only mito-K ATP channels exist on the PC12 mitochondrial membrane, the situation can not be deduced to other types of cells [11, 16] . Liu et al. had proved that the possible reasons for the protection of K ATP were associated with transcriptional process. Similarly like an enhanced expression of genes which promote cell survival or a suppressed expression of genes which cause cell death [17] . As the rotenone-induced cell death is associated with cell shrinkage, a distinct feature of apoptosis, meanwhile, surviving cells preconditioned with the mitochondrial K ATP channel opener shows no sign of cell shrinkage, the observed protection may be via the inhibition of apoptotic processes. The protection of K ATP channels on neuronal apoptosis is mediated by increasing mitochondrial Bcl-2 level anddecreasing mitochondrial Bax level, a pro-apoptotic member of the Bcl-2 family [18] [19] . Other investigations of the protection mechanism of mitochondrial K + channel suggest that the opening of mito-K ATP induced by increasing reactive oxygen species (ROS) production combines with blunting mitochondrial Ca 2+ accumulation, which finally improves the mitochondrial energy production [20] . As hydrogen peroxide (H 2 O 2 ) generate in all cells by mitochondrial respiration, Avshalumov MV examined regulation of K ATP channels in nigral dopaminergic neurons to certain the relationship between H 2 O 2 with mito-K ATP channels [21] [22] . The observation confirms an essential role of H 2 O 2 in activating K ATP channels. It indicates that endogenous H 2 O 2 acts in a graded manner to regulate tonic dopaminergic activity and responsiveness to oxidative challenge via K ATP channels. In addition, other intracellular factors like phosphoinositol phosphates (e.g. PIP2), G proteins, or protein kinases could modulate the metabolic sensitivity of K ATP channels as well [13, 22] . One has to be highlighted is that the regulation of cell activity by H 2 O 2 and metabolic sensitivity of mito-K ATP channels is mainly determined by the alternative expression of SUR subunits. After acute rotenone-induced K ATP channel activation in mouse brain slices, only highly responsive dopaminergic neurons expressing the K ATP channel subunits SUR1 and Kir6.2 [20] [21] [22] . The other population of dopaminergic neurons in substantia nigra pars compacta (SNpc), which express the other SUR isoform, maintain their pacemaker activity as a response to their partial mitochondrial respiratory chain complex I (CXI) inhibition [13, 15, 21, 23] .
K ATP channels are required in regulation of neurotransmitter release
The opening of K ATP channels may result in hyperpolarizing the membrane potential, inhibiting neurotransmitter release, regulating dopamine release in the striatum or glutamate and g-aminobutyric acid (GABA) release in the substantia nigra pars recticulata, and inhibiting glutamatergic transmission in the brain regions(e.g. globus pallidus and substantia nigra pars reticulate) to play critical roles in anti-parkinsonian effects [24] . Previous studies have emphasized that the mechanisms underlying the symptoms of PD involved in the increased GABA transmission in the globus pallidu and the regulation roles of K ATP -like channels of the basal ganglia in dopamine release as well as glutamate and GABA release in the substantia nigra in response to various environmental stimuli [25] . Therefore, the activation of K ATP channels openers in some brain regions(e.g. the corpus striatum, globus pallidus, subthalamic nucleus and substantia nigra), which results in neuron hyperpolarizing, dampening excitability and decreasing transmitter release (including decreasing the K + -evoked GABA release in pallidal slices), can have anti-parkinsonism effect. Moreover, K ATP channels modulate dopamine (DA) outflow from different slices of the rat caudate nucleus by biochemical study also provides evidence for the role of K ATP channels in the modulation of neurotransmitter release. Two different types of plasmalemmal K ATP channels have been comfirmed: one type with highaffinity binding sites mainly localized on the excitatory neurons, the other with low-affinity binding sites localized on the inhibitory neurons releasing GABA [26] .
K ATP channels are involved in selective vulnerability of SNpc to degeneration
The pathological hallmark of PD is the selective degeneration of a subpopulation of dopaminergic midbrain neurons, mainly in the SNpc [1] . The metabolic challenges with parkinsonism-inducing toxins, such as MPTP, cause rapid hyperpolarization and electrical "silencing" of dopaminergic neurons in the substantia nigra, where appears highly vulnerable to the degenerative process, but other areas, e.g. ventral tegmental area (VTA) remain largely unaffected. Liss et al. found that adult SN dopaminergic as well as VTA dopaminergic neurons possessed functional K ATP channels with the same molecular make-up. Nevertheless, in the dopaminergic neurons of VTA, K ATP channels were not activated and electrical activity was not altered by inhibition of complex I of the mitochondrial respiratory chain. Interestingly, dopaminergic neurons of VTA area expressed higher levels of uncoupling protein 2 (UCP-2) which may be upstream of K ATP in determining vulnerability of dopaminergic neurons in the substantia nigra [27] . These studies suggest that K ATP channel may eventually help determine whether a dopaminergic neuron lives or dies. In addition, as the degeneration in a subpopulation of dopaminergic neurons in the SNpc of PD, the brain may adjust to the loss of these cells through increasing activity of remaining cells, which is called "the compensatory mechanisms". The "selectively-escape-system" inner working manner or whether K ATP channels take any part in additional amounts of dopaminergic neurons survival, however, need to be further studied.
To sum up, K ATP channels are well recognized for their ability to couple membrane excitability with cellular energetic status and to be effectors acting as an endogenous defense mechanism against neuronal injury which induced by ATP depletion, oxidative stress, mitochondrial dysfunction and neurochemicals releasing. In addition, the K ATP channel activation can induce the expression of the 70,000 molecular weight class of heat shock proteins(HSP), which act as chaperones to restore the normal functioning of stress-damaged proteins by refolding or reassembling them. Further studies are needed to verify whether HSPs are involved in the K ATP channel-mediated protection against rotenone toxicity [28] .
Therapeutic targets and potential for PD
Though K ATP channels in the brain do not open under normal conditions, they often serve as a protective mechanism under stress and show significantly up-regulated expression in many pathophysiological conditions, such as in PD and ischemia/hypoxia, which involved in metabolic inhibition. The traditional choice of therapeutic intervention of PD uses dopamine agonists and L-dopa (Ldihydroxyphenylalanine), which often improve the motor impediments and severe dose-response fluctuations (onoff-phenomenon), hallucinations, uncontrollable dyskinesia, but can not prevent the progress of the disease. Special attention must be paid to avoid above side effects of the conventional therapy, and identify additional targets for potential pharmacological intervention. The utilization of the K ATP channels properties makes a new direction in the pharmacology of ion channels for PD [29] . In accordance with this view, the K ATP channel openers (K ATP COs) which are the novel synthetic molecules and have the ability to induce K ATP potassium conductance, are thought to act as an external factor to improve the opening of K ATP channels. They may offer beneficial effects against metabolic inhibitors to injury which plays a causative role in the etiology of a number of neurodegenerative diseases and are recognized as neuroprotective drugs. Nevertheless, someone hold the opinion that in PD transient K ATP channel activation is a short-term neuroprotective response to metabolic stress, but chronic K ATP channel activation could have fatal consequences for the dopaminergic neurons, in respect that a chronic reduction of neuronal activity and ATP consumption might lead to a reduced expression of some activitydependent genes (such as neurotrophins) which can promote cell survival [30] [31] . ATP-sensitive potassium channels can be attractive candidates for novel therapeutic regimes. The reasons are that the K ATP channels are selectively expressed in nervous structures which are important for pathological changes and neuropsychiatric symptoms of PD. In this case, activation or inhibition of K ATP channels may influence the clinical situation of affected patients. Otherwise, the molecular diversity of the channels should allow the development of highly specific drugs, which may selectively target cell types, groups, or systems throughout the body, correcting or at least improving disturbed functions [32] . In this respect, it is important to understand the regional, cellular, and subcellular localizations of identified ATP-sensitive potassium channel subunits. Consequently, K ATP channels are of meaningful neuropathological features in PD as an indication in the process of neuronal channelopathies and subsequent participation in the propagation of the neurodegeneration, which deserves further pursuit for making comprehensive use of their novel therapeutic potential.
